To include your compound in the COVID-19 Resource Center, submit it here.

Denali climbs after $250M IPO

Denali Therapeutics Inc. (NASDAQ:DNLI) jumped $3.45 (19%) to $21.45 in its first day of trading Friday after it raised $250 million through the sale of 13.9 million shares

Read the full 283 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE